Neurobehavioral Impairment in Pediatric Brain Tumor Survivors: A Meta-Analysis

Yuliang Wang1, Anthony Pak Yin Liu1,2, Tatia Mei-Chun Lee3,4

  • 1Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China.

Cancers
|July 9, 2022
PubMed

Insights

Pediatric brain tumor survivors face increased risks of emotional, psychosocial, and attention problems. Regular neurobehavioral monitoring is recommended for these individuals.

Area of Science:

  • Neuroscience
  • Pediatric Oncology
  • Psychology

Background:

  • Neurocognitive outcomes in pediatric brain tumor survivors (PBTS) are studied, but neurobehavioral impairment risks are less defined.
  • Understanding emotional, psychosocial, and attention issues is crucial for long-term survivor care.

Purpose of the Study:

  • To systematically analyze the rates and predictors of emotional, psychosocial, and attention problems in PBTS.
  • To quantify the risk of neurobehavioral impairment in this population.

Main Methods:

  • Systematic literature search of major databases (PubMed, Web of Science, Embase, Scopus, Cochrane) from 2012 to 2022.
  • Inclusion of studies reporting neurobehavioral outcomes for PBTS aged 2 to <23 years.
  • Random-effect meta-analysis to synthesize findings.

Main Results:

  • The estimated risks for emotional, psychosocial, and attention problems were 15%, 12%, and 12%, respectively.
  • PBTS showed significantly higher rates of emotional, psychosocial, and attention difficulties compared to healthy controls.
  • No significant difference in neurobehavioral impairment was found between survivors with or without cranial radiotherapy history.

Conclusions:

  • PBTS are at an elevated risk for neurobehavioral impairment.
  • Neurobehavioral monitoring should be integrated into the standard care for PBTS.
  • Further research may explore specific predictors and interventions.

Related Concept Videos